|
End-of-day quote
Shenzhen S.E.
2026-09-14
|
5-day change | 1st Jan Change | ||
| 11.44 CNY | +0.09% |
|
-3.30% | -22.55% |
| 08-28 | Sunflower Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-28 | Sunflower Pharmaceutical Withdraws Investment in Fund | MT |
Company Valuation: Sunflower Pharmaceutical Group Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 8,527 | 9,495 | 13,469 | 15,172 | 11,966 | 8,626 |
| Change | - | 11.35% | 41.85% | 12.65% | -21.13% | -27.92% |
| Enterprise Value (EV) 1 | 6,889 | 7,446 | 10,057 | 11,597 | 9,677 | 6,134 |
| Change | - | 8.08% | 35.07% | 15.31% | -16.56% | -36.62% |
| P/E | 14.7x | 13.6x | 15.7x | 13.5x | 24.4x | -33.6x |
| PBR | 2.66x | 2.61x | 3.22x | 3.19x | 2.73x | 2.25x |
| PEG | - | 0.6x | 0.7x | 0.5x | -0.4x | 0x |
| Capitalization / Revenue | 2.46x | 2.13x | 2.64x | 2.66x | 3.54x | 3.72x |
| EV / Revenue | 1.99x | 1.67x | 1.97x | 2.03x | 2.87x | 2.65x |
| EV / EBITDA | 8.52x | 7.97x | 7.84x | 8.55x | 15.5x | -48.6x |
| EV / EBIT | 10.4x | 9.65x | 9.84x | 9.8x | 21.4x | -21x |
| EV / FCF | 10.1x | 10.5x | 6.48x | 31x | -19.2x | 10.1x |
| FCF Yield | 9.88% | 9.52% | 15.4% | 3.22% | -5.21% | 9.89% |
| Dividend per Share 2 | 0.35 | 0.7 | 1 | 1.5 | 0.5 | 0.2 |
| Rate of return | 2.39% | 4.25% | 4.31% | 5.77% | 2.44% | 1.35% |
| EPS 2 | 1 | 1.21 | 1.48 | 1.92 | 0.84 | -0.44 |
| Distribution rate | 35% | 57.9% | 67.6% | 78.1% | 59.5% | -45.5% |
| Net sales 1 | 3,462 | 4,461 | 5,095 | 5,700 | 3,377 | 2,318 |
| EBITDA 1 | 809 | 933.8 | 1,283 | 1,356 | 625.7 | -126.2 |
| EBIT 1 | 661.9 | 771.3 | 1,022 | 1,184 | 452.8 | -291.6 |
| Net income 1 | 584.5 | 704.7 | 867.2 | 1,119 | 492 | -257.8 |
| Net Debt 1 | -1,638 | -2,049 | -3,411 | -3,576 | -2,289 | -2,492 |
| Reference price 2 | 14.67 | 16.46 | 23.18 | 25.98 | 20.49 | 14.77 |
| Nbr of stocks (in thousands) | 581,265 | 576,870 | 581,050 | 584,000 | 584,000 | 584,000 |
| Announcement Date | 4/20/21 | 4/21/22 | 4/11/23 | 4/25/24 | 4/24/25 | 4/26/26 |
1CNY in Million2CNY
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 995M | |
| 16.2x | 1.93x | 13.04x | 5.54% | 13.4B | |
| 25.75x | 1.44x | 9.53x | 2.12% | 4.78B | |
| 15.15x | 3.06x | 9.39x | 6.53% | 4.36B | |
| 16.88x | - | - | 1.38% | 3.78B | |
| 25.77x | - | - | - | 3.43B | |
| 15.69x | 2.25x | 9.42x | 2.77% | 3.12B | |
| Average | 19.24x | 2.17x | 10.35x | 3.67% | 4.84B | |
| Weighted average by Cap. | 18.48x | 2.07x | 11.33x | 4.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 002737 Stock
- Valuation Sunflower Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
